These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37463838)

  • 1. Natural killer cell-mediated contact dermatitis-like reaction induced by treatment with TLR3 ligand poly(I:C).
    Majewska-Szczepanik M; Kowalczyk P; Askenase PW; Szczepanik M
    Contact Dermatitis; 2023 Oct; 89(4):230-240. PubMed ID: 37463838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.
    Jin JO; Yu Q
    J Leukoc Biol; 2013 Mar; 93(3):413-25. PubMed ID: 23271706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
    Sun R; Gao B
    Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.
    Ngoi SM; Tovey MG; Vella AT
    J Immunol; 2008 Dec; 181(11):7670-80. PubMed ID: 19017955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions.
    Zhang M; Han Y; Han C; Xu S; Bao Y; Chen Z; Gu Y; Xia D; Cao X
    Hepatology; 2009 Nov; 50(5):1606-16. PubMed ID: 19821527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.
    Salem ML; El-Naggar SA; Mobasher MA; Elgharabawy RM
    J Immunol Res; 2020; 2020():2489407. PubMed ID: 32211442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells.
    McCartney S; Vermi W; Gilfillan S; Cella M; Murphy TL; Schreiber RD; Murphy KM; Colonna M
    J Exp Med; 2009 Dec; 206(13):2967-76. PubMed ID: 19995959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase Btk is required for NK cell activation.
    Bao Y; Zheng J; Han C; Jin J; Han H; Liu Y; Lau YL; Tu W; Cao X
    J Biol Chem; 2012 Jul; 287(28):23769-78. PubMed ID: 22589540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.
    Salem ML; El-Naggar SA; Kadima A; Gillanders WE; Cole DJ
    Vaccine; 2006 Jun; 24(24):5119-32. PubMed ID: 16704888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice.
    Salem ML; Diaz-Montero CM; El-Naggar SA; Chen Y; Moussa O; Cole DJ
    Vaccine; 2009 Jan; 27(4):549-57. PubMed ID: 19027047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR3 Modulates the Response of NK Cells against
    Qu J; Li L; Xie H; Zhang X; Yang Q; Qiu H; Feng Y; Jin C; Dong N; Huang J
    J Immunol Res; 2018; 2018():7519856. PubMed ID: 30246036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta.
    Duluc D; Tan F; Scotet M; Blanchard S; Frémaux I; Garo E; Horvat B; Eid P; Delneste Y; Jeannin P
    Eur J Immunol; 2009 Oct; 39(10):2877-84. PubMed ID: 19728309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
    Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
    J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3 impairment in human newborns.
    Slavica L; Nordström I; Karlsson MN; Valadi H; Kacerovsky M; Jacobsson B; Eriksson K
    J Leukoc Biol; 2013 Nov; 94(5):1003-11. PubMed ID: 23901120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation.
    Liu J; Liu S; Xia M; Xu S; Wang C; Bao Y; Jiang M; Wu Y; Xu T; Cao X
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7814-9. PubMed ID: 23610400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation.
    Ebihara T; Azuma M; Oshiumi H; Kasamatsu J; Iwabuchi K; Matsumoto K; Saito H; Taniguchi T; Matsumoto M; Seya T
    J Exp Med; 2010 Nov; 207(12):2675-87. PubMed ID: 21059856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.